comparemela.com

Inventiva (IVA) announces changes to the clinical development of lanifibranor, including plans for a new Phase III trial in patients with NASH and compensated cirrhosis

Inventiva (IVA) announces changes to the clinical development of lanifibranor, including plans for a new Phase III trial in patients with NASH and compensated cirrhosis
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

United States ,Michael Cooreman ,Sven Francque ,Donna Cryer ,Tarun Sanyal ,Antwerp University Hospital ,Virginia Commonwealth University ,Drug Administration ,Stravitz Sanyal Institute For Liver Disease ,Metabolic Health ,Nasdaq ,Global Liver Institute ,Euronext Paris ,Fast Track ,Breakthrough Therapy ,Chief Medical Officer ,Stravitz Sanyal Institute ,Liver Disease ,Nasdaq Global Market ,

comparemela.com © 2020. All Rights Reserved.